FUJIFILM Diosynth Biotechnologies

Home      Contact Us     Careers     Site Map          LinkedIn Facebook Twitter Contact Us



The acquisition of Kalon Biotherapeutics LLC in December 2014 provides significant viral and cell culture vaccine expertise and capabilities, adding to our existing competencies in microbial, mammalian and insect cell biopharmaceuticals.
FUJIFILM Diosynth Biotechnologies' scientists have researched the key components in the generation of a recombinant cell line, and as a result have created our new Apollo™ mammalian expression platform.

pAVEway™ is our proprietary and proven technology for the efficient expression of therapeutic proteins. It has recently been improved to permit large-scale protein manufacture using antibiotic-free microbial fermentations.

We have a strong mammalian track record that includes a 'gene to GMP' service, offering cell line and process development leading to cGMP manufacture for clinical and commercial product.




Home   About us   Process Development   GMP Contract Manufacturing   Working with Us   Quality   Careers   Contact Us   Site Map

Copyright 2015 FUJIFILM Diosynth Biotechnologies UK Ltd.

Legal Statement and Disclaimer


We use cookies to help understand how people use our website. By using our site, you agree to our use of cookies. Find out more in our privacy policy.